1046 related articles for article (PubMed ID: 32204538)
1. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
[TBL] [Abstract][Full Text] [Related]
2. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
Del Chierico F; Nobili V; Vernocchi P; Russo A; De Stefanis C; Gnani D; Furlanello C; Zandonà A; Paci P; Capuani G; Dallapiccola B; Miccheli A; Alisi A; Putignani L
Hepatology; 2017 Feb; 65(2):451-464. PubMed ID: 27028797
[TBL] [Abstract][Full Text] [Related]
4. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
[TBL] [Abstract][Full Text] [Related]
6. Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Abdollahiyan S; Nabavi-Rad A; Keshavarz Azizi Raftar S; Monnoye M; Salarieh N; Farahanie A; Asadzadeh Aghdaei H; Zali MR; Hatami B; Gérard P; Yadegar A
Sci Rep; 2023 Nov; 13(1):20584. PubMed ID: 37996480
[TBL] [Abstract][Full Text] [Related]
7. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.
Zhang J; Shi M; Zhao C; Liang G; Li C; Ge X; Pei C; Kong Y; Li D; Yang W; Cao B; Fu L; Yan Y; Wu J; Zhou J; Fang Y; Meng X; Li Y; Wang L
Microbiol Spectr; 2024 Feb; 12(2):e0100623. PubMed ID: 38189294
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
10. Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
Demir M; Lang S; Martin A; Farowski F; Wisplinghoff H; Vehreschild MJGT; Krawczyk M; Nowag A; Scholz CJ; Kretzschmar A; Roderburg C; Lammert F; Goeser T; Kasper P; Steffen HM
J Gastroenterol Hepatol; 2020 Nov; 35(11):1969-1977. PubMed ID: 32267559
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance.
Da Silva HE; Teterina A; Comelli EM; Taibi A; Arendt BM; Fischer SE; Lou W; Allard JP
Sci Rep; 2018 Jan; 8(1):1466. PubMed ID: 29362454
[TBL] [Abstract][Full Text] [Related]
12. Variation in the Plasma Levels of Polyunsaturated Fatty Acids in Control vis-à-vis Nonalcoholic Fatty Liver Disease Subjects and Its Possible Association with Gut Microbiome.
Vernekar M; Singhal R; Joshi K; Amarapurkar D
Metab Syndr Relat Disord; 2018 Sep; 16(7):329-335. PubMed ID: 29873593
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease.
Pan X; Kaminga AC; Liu A; Wen SW; Luo M; Luo J
Front Cell Infect Microbiol; 2021; 11():683743. PubMed ID: 34778099
[TBL] [Abstract][Full Text] [Related]
14. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
15. Lower gut microbiome diversity and higher abundance of proinflammatory genus
Astbury S; Atallah E; Vijay A; Aithal GP; Grove JI; Valdes AM
Gut Microbes; 2020 May; 11(3):569-580. PubMed ID: 31696774
[TBL] [Abstract][Full Text] [Related]
16. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
[TBL] [Abstract][Full Text] [Related]
17. From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients.
Huang F; Lyu B; Xie F; Li F; Xing Y; Han Z; Lai J; Ma J; Zou Y; Zeng H; Xu Z; Gao P; Luo Y; Bolund L; Tong G; Fengping X
Front Microbiol; 2024; 15():1366744. PubMed ID: 38638907
[TBL] [Abstract][Full Text] [Related]
18. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
19. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity.
Nistal E; Sáenz de Miera LE; Ballesteros Pomar M; Sánchez-Campos S; García-Mediavilla MV; Álvarez-Cuenllas B; Linares P; Olcoz JL; Arias-Loste MT; García-Lobo JM; Crespo J; González-Gallego J; Jorquera Plaza F
Rev Esp Enferm Dig; 2019 Apr; 111(4):275-282. PubMed ID: 30810328
[TBL] [Abstract][Full Text] [Related]
20. Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.
Hamid H; Zhang JY; Li WX; Liu C; Li ML; Zhao LH; Ji C; Ma QG
Poult Sci; 2019 Jun; 98(6):2509-2521. PubMed ID: 30690636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]